SCHEMBL14433403

SCHEMBL14433403

O[C@@H]1Cc2cc(F)ccc2N1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR5A P47898 4/20 0.39
CHRNB2 P17787 2/20 0.36
CHRNB4 P30926 2/20 0.36
CHRNA3 P32297 2/20 0.36
CHRNA4 P43681 2/20 0.36
CHRNA7 P36544 1/20 0.36
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
PDE3A Q14432 1/20 0.33
ADRA2A P08913 1/20 0.33
ADRA2B P18089 1/20 0.33
ADRA2C P18825 1/20 0.33
SLC6A4 P31645 1/20 0.33
ACHE P22303 1/20 0.33
NOS3 P29474 1/20 0.32
NOS2 P35228 1/20 0.32
HTR2A P28223 1/20 0.31
HTR2C P28335 1/20 0.31
LMNA P02545 1/20 0.31
GAA P10253 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15145693 1.00 HTR5A (0.39) HTR5ACHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL29155359 0.78 HTR5A (0.40) HTR5ACHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL23016970 0.77 PNMT (0.37) ADRA2AADRA2BADRA2CLMNAGAA
SCHEMBL29529402 0.77 LMNA (0.46) HTR5ACHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL23788032 0.77 HTR5A (0.38) HTR5APDE3AACHELMNAGAA
SCHEMBL8937088 0.77 LMNA (0.46) HTR5ACHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL30681298 0.77 LMNA (0.46) HTR5ACHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL27461755 0.75 GAA (0.60) HTR5AGAAMAPT
SCHEMBL27303285 0.75 GAA (0.60) HTR5AGAAMAPT
SCHEMBL31083392 0.74 CHRNB2 (0.41) HTR5ACHRNB2CHRNB4CHRNA3CHRNA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007087419-A2 SUBSTITUTED 3-(5-MEMBERED UNSATURATED HETEROCYCLYL) -1, 3-DIHYDRO-INDOL-2-ONE DERIVATIVES AS TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF CANCER ALLERGAN, INC. (US) 2007-08-02 WO disclosed